In NSCLC without brain metastasis at the time of initial diagnosis, there were 35/58 cases (60.34%) of brain metastasis in the high level NSE group and 71/252 cases (28.17%) in the low level NSE group at the end of follow-up. Here, ENO2 is linked to non-small cell lung carcinoma.